Product Images Duloxetine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 11 images provide visual information about the product associated with Duloxetine NDC 63629-5202 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This appears to be a label or packaging information for a medication. The medication name is not available as it is not mentioned in the given text. It is packaged by Bryant Ranck Prepack and is being compared to Cymbalta 60mg Capsule manufactured by Sun Pharma Global FZE. The package contains 30 capsules and the expiration is mentioned as MM/YY (month/year). It also has an NDC number. The rest of the text contains storage instructions and a cautionary message to keep drugs out of reach of children.*
This appears to be a graph showing the proportion of patients with relapse over time from randomization to relapse. The x-axis represents the time in days, and the y-axis represents the percentage of patients who experienced relapse at that time point. The graph appears to show that as time from randomization to relapse increases, the proportion of patients experiencing relapse decreases. There are three lines on the graph, each representing a different treatment group, though the actual treatments are not specified in the available text.*
The text describes the percentage improvement in pain from baseline for patients taking either placebo or different dosages of a drug called Duloxetine. Dosages vary from 60mg to 120mg, and the drug is taken once daily. The chart provided shows the percentage of pain improvement at different time points and doses.*
This is a graph that shows the proportion of patients with relapse over time from randomization to relapse (measured in days) for a specific treatment (duloxetine) compared to a placebo. The graph displays the percentage of patients with relapse on the y-axis and time in days on the x-axis. The treatment group appears to have a lower proportion of patients with relapse over the observed time period compared to the placebo group.*
This appears to be a chart showing the percentage of patients who have improved in pain, with the x-axis representing the percentage improvement in pain from baseline and the y-axis representing the percentage of patients improved. It is not possible to discern any additional information without further context or data.*
This appears to be a chart displaying the percentage improvement in pain from baseline for a placebo and Duloxetine 60mg taken daily. There are various data points on the chart ranging from 210 to 280, with corresponding percentage improvements in pain indicated.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.